Eye Health Supplements Market to Survive with Innovations at 6% CAGR

by time news

Increasing incidence of age-related macular degeneration (AMD), cataract, etc., is expected to drive the growth of the eye health supplements market. Also, the increasing adoption of eye supplements as preventive medications among the aging population is expected to further drive the Eye health supplements market . Besides, the availability of a variety of effective eye health supplements with refined distribution network across the globe is also expected to aid the market growth during the forecast period. Increasing demand for eye health supplements in developed regions such as European countries with a higher proportion of aging population is expected to create a significant opportunity for players in the global eye health supplements market.

Increasing investments in research and product development while collaborating with various local distribution networks by key stakeholders in the eye health supplements market is expected to boost market growth. The global eye health supplements market was estimated at -2 billion dollars in 2019, and is expected to be presented CAGR of 6% during the forecast period (2019-2029).

Get a sample copy of this report @ https://www.persistencemarketresearch.com/samples/5465

Company profiles:

  • Pfizer Ltd
  • Novartis AG
  • Bausch Health
  • Amway Corp
  • Vitabiotics Ltd
  • Alliance Pharma
  • Nature’s Bounty Co

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/5465

Market research of dietary supplements for eye health

  • Based on ingredient, due to superior product efficacy, lutein-zeaxanthin and the antioxidant segment together generated over 60% market value share in the global eye health supplements market in 2018.
  • The increasing prevalence of age-related macular degeneration (AMD) worldwide makes it the most profitable segment in the disease indication, and with the increasing adoption of eye health supplements as a preventive treatment, a similar trend is expected to continue during the forecast period.
  • In terms of dosage form, tablets and capsules, together, contributed about 3/4 market value share in the eye health supplements market, due to widespread availability and high adoption by patients.
  • North America accounted for over 1/3 of the market value share and is expected to be the most profitable region in the global eye health supplements market during the forecast period.

“Continued focus on developing new treatment options for degenerative diseases such as AMD is expected to drive the growth of the global eye health supplements market. As far as the expected impact of COVID-19 is concerned, the pandemic will, in fact, create a greater need for enhanced immunity. With immunity boosting and preventive healthcare taking the front seat, opportunities will emerge for manufacturers of eye health supplements communicate their role as key micronutrients says a PMR analyst.

Product launch – a necessary strategy for the market players

Market introduction of new products as per disease need is the major factor responsible for fierce competition among market players in the global eye health supplements market. Several companies are focusing on launching preservative-free solutions to increase sales of their products and expand market share. For example, in June 2018, Bausch + Lomb, a subsidiary of Valeant Pharmaceuticals International, launched preservative-free lubricant drops – Soothe Xtra Protection – to address the growing issue of dry eye disorder.

Access the full report @ https://www.persistencemarketresearch.com/checkout/5465

What else is in the report?

Persistence Market Research offers a unique perspective and actionable insights on the eye health supplement market in its latest study, which presents historical demand assessment 2014-2018 and forecasts 2019-2029, based on ingredient (lutein and zeaxanthin, antioxidants, omega-3 fat). acids, coenzyme q10, flavonoids, astaxanthin, alpha-lipoic acid and other ingredients), disease indication (age-related macular degeneration (AMD), cataracts, dry eye syndrome, and other indications), and form (tablets, capsules, and others), across seven key areas.

About us: Persistence market research

Contact Us:

Persistence Market Research Address
– 305 Broadway, 7th Floor, New York City, NY 10007 United States
US Ph. – +1-646-568-7751
US-Canada toll free – +1 800-961-0353
Salessales@persistencemarketresearch .com

You may also like

Leave a Comment